Rapport Therapeutics, Inc. Common Stock (RAPP) — Defensive Interval Ratio
Rapport Therapeutics, Inc. Common Stock (RAPP) has a Defensive Interval Ratio of 8133 days as of March 2026. Defensive assets of $398.78 Million (cash $-, short-term investments $398.73 Million, receivables $58.00K) cover 8133 days of daily cash needs of $49.03K/day. Check Rapport Therapeutics, Inc. Common Stock (RAPP) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Rapport Therapeutics, Inc. Common Stock Defensive Interval Ratio (2022–2025)
This chart shows how Rapport Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of March 2026, the ratio stands at 8133 days, meaning defensive assets of $398.78 Million can fund 8133 days of operations without new revenue. Also explore Rapport Therapeutics, Inc. Common Stock equity growth rate to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Rapport Therapeutics, Inc. Common Stock (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for Rapport Therapeutics, Inc. Common Stock from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see RAPP stock market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 8391 days | $437.89 Million | $52.19K/day | $- | $437.89 Million | ▼ -1954 days |
| 2024 | 10345 days | $248.47 Million | $24.02K/day | $- | $248.47 Million | ▲ +7139 days |
| 2023 | 3205 days | $77.31 Million | $24.12K/day | $- | $77.31 Million | ▲ +3205 days |
| 2022 | 0 days | $0.00 | $4.56K/day | $- | $0.00 | — |